These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 4019810)
21. Fluoxetine and desipramine in major depressive disorder. Bowden CL; Schatzberg AF; Rosenbaum A; Contreras SA; Samson JA; Dessain E; Sayler M J Clin Psychopharmacol; 1993 Oct; 13(5):305-11. PubMed ID: 8227488 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and feasibility of high dose tricyclic antidepressant treatment in elderly delusional depressives. Brown RP; Kocsis JH; Glick ID; Dhar AK J Clin Psychopharmacol; 1984 Dec; 4(6):311-5. PubMed ID: 6511997 [TBL] [Abstract][Full Text] [Related]
23. Symptom exacerbation in psychotically depressed adolescents due to high desipramine plasma concentrations. Conrad CD; Kudler HS J Clin Psychopharmacol; 1986 Jun; 6(3):161-4. PubMed ID: 2872236 [TBL] [Abstract][Full Text] [Related]
24. 2-Hydroxydesipramine and desipramine plasma levels: how are they related to antidepressant response? Stern SL; Cooper TB; Nelson LD; Johnson MH; Suckow RF Int Clin Psychopharmacol; 1996 Dec; 11(4):219-27. PubMed ID: 9031987 [TBL] [Abstract][Full Text] [Related]
25. Patterns of plasma imipramine-desipramine concentrations in patients receiving concomitant fluphenazine decanoate. Siris SG; Adan F; Lee A; Cooper TB; Mandeli J; Casey E J Clin Psychiatry; 1988 Feb; 49(2):64-5. PubMed ID: 3338977 [TBL] [Abstract][Full Text] [Related]
26. [Pharmacological treatment of delusional depression]. Amore M; Giordani L; Giorgetti G; Zazzeri N Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200 [TBL] [Abstract][Full Text] [Related]
27. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test. Coote M; Wilkins A; Werstiuk ES; Steiner M J Psychiatry Neurosci; 1998 May; 23(3):172-8. PubMed ID: 9595891 [TBL] [Abstract][Full Text] [Related]
28. Desipramine dose prediction based on 24-hour single-dose levels: feasibility and validity. Bertschy G; Vandel S; Vandel B; Allers G; Bechtel P; Volmat R Pharmacopsychiatry; 1989 Jul; 22(4):161-4. PubMed ID: 2762378 [TBL] [Abstract][Full Text] [Related]
29. Desipramine treatment of major depression in patients over 75 years of age. Nelson JC; Mazure CM; Jatlow PI J Clin Psychopharmacol; 1995 Apr; 15(2):99-105. PubMed ID: 7782495 [TBL] [Abstract][Full Text] [Related]
30. Acute noradrenergic effects of desipramine in depression. Rudorfer MV; Sherer MA; Lane EA; Golden RN; Linnoila M; Potter WZ J Clin Psychopharmacol; 1991 Feb; 11(1):22-7. PubMed ID: 2040714 [TBL] [Abstract][Full Text] [Related]
31. Plasma concentrations of tricyclic antidepressants in clinical practice. Hollister LE J Clin Psychiatry; 1982 Feb; 43(2):66-9. PubMed ID: 7056706 [TBL] [Abstract][Full Text] [Related]
33. Excessive plasma concentration of tricyclic antidepressants resulting from usual doses: a report of six cases. Devane CL; Wolin RE; Rovere RA; Panahon NC; Sutfin TA; Jusko WJ J Clin Psychiatry; 1981 Apr; 42(4):143-7. PubMed ID: 7204359 [TBL] [Abstract][Full Text] [Related]
34. The effect of desipramine on body weight in depression. Levitt AJ; Joffe RT; Esche I; Sherret D J Clin Psychiatry; 1987 Jan; 48(1):27-8. PubMed ID: 3804981 [TBL] [Abstract][Full Text] [Related]
35. Plasma trazodone concentrations in elderly depressed inpatients: cardiac effects and short-term efficacy. Spar JE J Clin Psychopharmacol; 1987 Dec; 7(6):406-9. PubMed ID: 3429702 [TBL] [Abstract][Full Text] [Related]
36. Plasma trazodone concentrations and clinical response in elderly depressed patients: a preliminary study. Monteleone P; Gnocchi G; Delrio G J Clin Psychopharmacol; 1989 Aug; 9(4):284-7. PubMed ID: 2768543 [TBL] [Abstract][Full Text] [Related]
37. Imipramine and desipramine disposition in the elderly. Abernethy DR; Greenblatt DJ; Shader RI J Pharmacol Exp Ther; 1985 Jan; 232(1):183-8. PubMed ID: 3965690 [TBL] [Abstract][Full Text] [Related]
38. Does melancholia predict response in major depression? Nelson JC; Mazure CM; Jatlow PI J Affect Disord; 1990 Mar; 18(3):157-65. PubMed ID: 2139060 [TBL] [Abstract][Full Text] [Related]
39. Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation. Licht RW; Qvitzau S Psychopharmacology (Berl); 2002 May; 161(2):143-51. PubMed ID: 11981594 [TBL] [Abstract][Full Text] [Related]
40. Platelet serotonin uptake inhibition as a basis for monitoring antidepressant drug treatment. Lingjaerde O J Clin Psychopharmacol; 1984 Apr; 4(2):76-81. PubMed ID: 6231316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]